Epidemiological aspects of cardiovascular disease in the elderly

A E Fletcher1, C J Bulpitt

  • 1Epidemiology Research Unit, Royal Postgraduate Medical School, London, UK.

Insights

Cardiovascular disease risk factors persist in the elderly. While blood pressure reduction is recommended, more research is needed on cholesterol modification strategies for older adults.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a primary cause of mortality in industrialized societies' elderly populations.
  • Limited research focuses on CVD morbidity and mortality reduction strategies specifically for the elderly.

Purpose of the Study:

  • To review existing research on cardiovascular disease risk factors in the elderly.
  • To evaluate the evidence for risk factor modification effectiveness in this demographic.

Main Methods:

  • Systematic review of studies on cardiovascular disease risk factors in older adults.
  • Analysis of evidence from clinical trials and observational studies on risk factor modification.

Main Results:

  • Established CVD risk factors in middle-aged individuals generally persist in the elderly.
  • Serum cholesterol is linked to coronary heart disease risk, but its modification benefits in the elderly require further study.
  • Blood pressure reduction has demonstrated benefits up to age 84, though relationships in the very old may be non-linear.
  • Smoking is a reported risk factor in some, but not all, elderly populations.

Conclusions:

  • Currently, only the management of high blood pressure is definitively recommended for cardiovascular risk reduction in the elderly.
  • Further investigation into dietary and pharmacological cholesterol modification is warranted for older adults.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...